Finimize - 🕷 Spidey rescues Sony

Sony feels like a winner | Pfizer's bagged a big deal |

Hi Reader, here's what you need to know for May 11th in 3:14 minutes.

🤠 Crypto can feel like the Wild West these days, but there may be a few new sheriffs in town soon. Join Crypto Council for Innovation’s Sheila Warren for The Future Of Crypto Regulation on Wednesday, and find out what regulators have planned for this online boomtown. Grab your free ticket

Today's big stories

  1. Sony reported its highest full-year revenue ever
  2. A major shakeup this weekend proved that stablecoins aren’t always so “stable” after all – Read Now
  3. Pfizer announced its biggest deal in five years

Into The Sony-verse

Into The Sony-verse

What’s Going On Here?

Sony reported record full-year sales on Tuesday, after the entertainment giant came to the eye-opening realization that three Spider-Men are more profitable than one.

What Does This Mean?

Somewhere in this sprawling multiverse, there’s another Finimize reporting that Sony is in disarray after its latest Spider-Man movie unceremoniously flopped. This is not that universe, with Spider-Man: No Way Home having become one of the highest-grossing movies of all time. Throw in a long list of licensing agreements with streaming services, and Sony’s movie segment brought down the house last quarter.

Sony’s music and anime businesses performed well too, and there was big demand for its smartphone camera sensors. Put it all together, and the company posted its best-ever full-year sales – albeit with the caveat that the company’s profit came in 14% lower than the year before. It said it was expecting another drop of 6% this year too, which does make you wonder if Hotel Transylvania: Transformania was a shrewd investment.

Why Should I Care?

Zooming in: Microsoft might not be on top for long.
Sales of Sony’s PlayStation 5 faltered last year, but only because it’s still nearly impossible to get hold of one: the company doesn’t have enough of the parts it needs to meet demand. That’s put its sales well behind those of Microsoft’s Xbox models, which made record revenue in March. Sony, then, has been working hard to find new suppliers and design shortcuts, which it’s confident will help it get production back on track in next to no time.

The bigger picture: Sony’s built for this.
Sony makes a significant portion of its sales internationally, which is a fortunate position for a Japanese company to be in right now. See, the yen is at a 20-year low against the US dollar, largely because America’s rising interest rates (and Japan’s rock-bottom ones) have made US assets more appealing to international investors and savers. So when Sony converts its foreign revenue back into Japanese yen, it’ll be worth a lot more than it would’ve been otherwise.

Copy to share story: https://www.finimize.com/wp/news/into-the-sony-verse/

🙋 Ask a question

Analyst Take

Stablecoins Aren’t As “Stable” As They Seem

Stablecoins Aren’t As “Stable” As They Seem

By Jonathan Hobbs, Analyst

What’s Going On Here?

Terra had a rough time of it this weekend.

The blue chip blockchain’s stablecoin – which is pegged to the value of the US dollar – detached from that very peg. That’s… not supposed to happen.

It’s a shakeup that’s sent the price of Terra’s more volatile coin, Luna, down more than 60%, knocking the crypto out of the top 10 digital assets by market size.

But it’s also a timely reminder that for all their reputation as a less volatile crypto, stablecoins aren’t always what they’re cracked up to be.

So that’s today’s Insight: what exactly happened with Terra and Luna, and what you can take from it about the stablecoin market at large.

Read or listen to the Insight here

SPONSORED BY TRADESTATION

Old dogs, new tricks

The stock market’s been ruled by young bucks like Amazon, Apple, and Tesla recently.

But it looks like the old-timers are back to show them how it’s done: utilities and commodities stocks have been catching investors’ attention this year, according to a new TradeStation report.

Check it out for yourself: the chart above – created with TradeStation’s TradingView tool – shows insurance stock Traveler reached new highs earlier this month.

There’s more where that came from, and you can spot them all using TradeStation’s market-scanning tools.

Now sounds like a good time to get started: claim a $150 bonus when you sign up with TradeStation.

Check Out TradeStation

This content is for educational and informational purposes only. Any symbols, financial instruments, or trading strategies discussed are for demonstration purposes only and are not research or recommendations. TradeStation companies do not provide legal, tax, or investment advice.

Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or cryptocurrencies); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on our Important Documents & Information page.

Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission (“SEC”) and a futures commission merchant licensed with the Commodity Futures Trading Commission (“CFTC”). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association (“NFA”), and a number of exchanges. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services under federal and state money services business/money-transmitter and similar registrations and licenses.

TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly-owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. You Can Trade, Inc. is also a wholly-owned subsidiary of TradeStation Group, Inc., operating under its own brand and trademarks. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Click here for further important information explaining what this means.

Investing in cryptocurrencies involves significant risks. See the Investment and Trading Disclosures Booklet for more information on investing and trading in cryptocurrencies.

Finimize is not affiliated with TradeStation. TradeStation does not endorse any third-party content and any views or opinions expressed by Finimize do not necessarily represent the views and opinions of TradeStation Securities Inc. or any of its affiliates.

Drug Habits

Drug Habits

What’s Going On Here?

Pfizer announced plans on Tuesday to buy Biohaven Pharmaceutical in its biggest deal in five years.

What Does This Mean?

Pfizer’s facing an uphill battle going forward: sales of its Covid vaccine are expected to peter out sooner or later, and some of its biggest-selling cancer drugs are due to lose patent protection in the next few years. So the company’s putting some of its hard-profiteered cash to good use, having already bought drugmakers Trillium Therapeutics and Arena Pharmaceuticals late last year for around $2 billion and $7 billion respectively. It added to that roster on Tuesday, announcing plans to buy Biohaven Pharmaceutical in a deal worth almost $12 billion. The move will give Pfizer access to a migraine drug that brought in nearly $500 million in revenue last year, and is projected to bring in $1 billion by 2024.

Why Should I Care?

For markets: Patience is a virtue.
Pfizer’s putting up almost $149 for each of Biohaven’s shares – a hefty 78% more than they were worth before the deal was announced. Those kinds of premiums are a pretty standard way to convince the target’s shareholders to accept the deal, but Pfizer may have actually nabbed a bargain: Biohaven’s stock was trading at $143 as recently as mid-February.

The bigger picture: Better late than never, Novavax.
If Pfizer is the drugmaker that got the vaccine party started, Novavax is the one that turns up at midnight with a bottle of schnapps: the company reported its first profitable quarter this week, as its vaccines finally rolled out across the world (tweet this). The company was part of the US-backed race to develop a vaccine in 2020, but it missed out to the likes of Pfizer and Johnson & Johnson. Now, though, Novavax is hoping that its more traditional technology will appeal to holdouts, as though antivaxxers were only ever a protein-based solution away from civic-mindedness.

Copy to share story: https://www.finimize.com/wp/news/drug-habits/

🙋 Ask a question

💬 Quote of the day

“I saw the angel in the marble and carved until I set him free.”

– Michelangelo (an Italian sculptor, painter, architect, and poet)
Tweet this

SPONSORED BY TRADESTATION

Musk isn’t alone

Elon Musk’s bid for Twitter has made headlines around the world, to say the least.

But this isn’t the first time an investor has planned to take control of a company in hopes of rejuvenating its business model.

It won’t be the last, either: activist investors are taking the market by storm, according to recent research by the market experts at TradeStation.

Dollar Tree, for one, saw its share price climb after activist investors proposed big changes to the company’s board. Just check out the chart above, made with TradeStation’s TradingView tool.

Make sure you see the next boom coming: get a $150 bonus when you sign up for TradeStation today.

Find Out More

This content is for educational and informational purposes only. Any symbols, financial instruments, or trading strategies discussed are for demonstration purposes only and are not research or recommendations. TradeStation companies do not provide legal, tax, or investment advice.

Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or cryptocurrencies); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on our Important Documents & Information page.

Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission (“SEC”) and a futures commission merchant licensed with the Commodity Futures Trading Commission (“CFTC”). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association (“NFA”), and a number of exchanges. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services under federal and state money services business/money-transmitter and similar registrations and licenses.

TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly-owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. You Can Trade, Inc. is also a wholly-owned subsidiary of TradeStation Group, Inc., operating under its own brand and trademarks. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Click here for further important information explaining what this means.

Investing in cryptocurrencies involves significant risks. See the Investment and Trading Disclosures Booklet for more information on investing and trading in cryptocurrencies.

Finimize is not affiliated with TradeStation. TradeStation does not endorse any third-party content and any views or opinions expressed by Finimize do not necessarily represent the views and opinions of TradeStation Securities Inc. or any of its affiliates.

When you support our sponsors, you support us. Thanks for that.

🎯 On Our Radar

  1. Meta might have to open up soon. This data leak might be for the best…
  2. Bored of your trading app? Here’s what it might take for a traditional institution to win you over.*
  3. Calling all hangry folk. You might have a lot in common with worms.
  4. We’ve got a new partner. Get the scoop from our very own Nik here.
  5. Batman’s just a side character. Fans have found their real hero.

When you support our sponsors, you support us. Thanks for that.

🌎 Finimize Live

🎉 Coming Up This Week

All events are in UK time.

👉 What’s Next For Crypto Regulation: 6pm, May 11th
📚 How To Go From Ideas To Execution: 5pm, May 12th
💻 How To Invest In The Up And Coming Tech Landscape: 5pm, May 13th
📈 How To Identify High Growth Metaverse Stocks: 12pm, May 16th
🙌 How To Invest In Community-Led Projects: 5pm, May 16th
🌎 How To Invest In The Global Chip Shortage: 5pm, May 17th
🏡 How To Buy A Digital Condo: 12pm, May 18th

💪 And Then After That…

🚗 The Leaders Of The EV Revolution: 5pm, May 19th
♻️ How To Pick Winning ESG Stocks: 5pm, May 20th
📈 How To Invest Thematically: 12pm, May 24th

❤️ Share with a friendYour Referrals: 0

Thanks for reading Reader. If you liked today's brief, we'd love for you to share it with a friend. If they sign up on your unique link, you’ll earn some sweet swag.

Share your unique link:

https://finimize.com/invite/?kid=177ZWC

You stay classy, Reader 😉

We’d love to hear your thoughts. Give feedback

Want to advertise with us too? Get in touch

Image Credits:

Image credits: Michael Vi - Shutterstock | New Africa, F16-ISO100 and Kwangmoozaa - Shutterstock

Preferences:

Update your email or change preferences

View in browser

Unsubscribe from all Finimize Emails

😴

Crafted by Finimize Ltd. | Bow Bells House, Bread Street, London, EC4M 9HH

All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at finimize.com or through one of our partners. © Finimize 2021

View Online

Older messages

🐌 China stops moving

Monday, May 9, 2022

China wants the best of both worlds | Tyson Foods licks its lips | TOGETHER WITH Hi Reader, here's what you need to know for May 10th in 3:09 minutes. Today's big stories Chinese trade barely

🇨🇳 China sabotages Adidas

Sunday, May 8, 2022

Adidas has had a tough run | The US really is the Land of Opportunity | TOGETHER WITH Hi Reader, here's what you need to know for May 9th in 3:15 minutes. 🚀 Space innovation won't just change

☕️ Bitcoin’s perked up again

Thursday, May 5, 2022

The Bank of England isn't wavering | Lufthansa went big | TOGETHER WITH Hi Reader, here's what you need to know for May 6th in 3:08 minutes. 🤯 The future is full of unknowns, especially when it

📈 The Fed hikes rates again

Wednesday, May 4, 2022

Uber's still got it | AMDaaaaym | TOGETHER WITH Hi Reader, here's what you need to know for May 5th in 3:05 minutes. 💸 Web3 is bringing a whole new world of investment opportunities, but they

📈 Pfizer shoots up

Tuesday, May 3, 2022

Buffett is done waiting | Pfizer isn't done vaccinating | TOGETHER WITH Hi Reader, here's what you need to know for May 4th in 3:07 minutes. 😛 Here's a tongue twister for you: ReFi can make

Snap: The Relentless Quest to Own the Interface

Monday, May 23, 2022

Plus! Media Convergence; What's Still Fundable; The Piracy Continuum; Crypto Relearns Regulation; Shrinking Alpha ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

The Daily StockTips Newsletter 05.23.2022

Monday, May 23, 2022

I've Screened the Market for what I Consider the Best, Safest, & Most RELIABLE Profit Opportunities! (Published 7:30 AM ET MON-FRI) ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Take a Peek at This Week's Schedule

Monday, May 23, 2022

Including: TWO Ellevest Explains! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

🤓 Should you cash in on Coinbase?

Sunday, May 22, 2022

Brits are numbing the pain | China says "cut" | TOGETHER WITH Hi Reader, here's what you need to know for May 23rd in 3:04 minutes. 💥 You – yes, you – are invited to the first-ever NFT

🚀 Navigating a new market

Sunday, May 22, 2022

Plus, announcing a16z's investment in Locale! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Longreads + Open Thread

Saturday, May 21, 2022

Regulatory Arbitrage, Mean Reversion, Replication, Bees, Specialization, Snap ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

The Best Colleges in America Right Now

Saturday, May 21, 2022

And the best college is... ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ May

Home Depot just crushed earnings. We visited a store and saw first-hand why.

Saturday, May 21, 2022

Rising home prices are good for Home Depot's business because homeowners invest in improving their homes. View in browser Business Insider Business Insider Business Insider Subscribe Business

Bright side of a bad week

Saturday, May 21, 2022

Bloomberg Weekend Reading View in browser Bloomberg Follow Us Get the newsletter US recession warnings are mounting in some quarters as the ties that bind the global economy look to be unraveling. Wall

Elon tweets, Tesla twists

Friday, May 20, 2022

Bloomberg Evening Briefing View in browser Bloomberg Tesla is limping to the finish line, as the stock's 14% decline this week makes it the second-biggest drag on the S&P 500 Index over the